Archive · 19 Dec 2025
Trump Administration Proposes Ending Gender-Affirming Care for Trans Youth
The Trump administration has proposed new rules to stop hospitals from providing gender-affirming care to people under 18.
This includes treatments like puberty-blocking drugs, hormone therapies, and surgeries.
They also want to stop Medicaid from paying for these treatments and have warned companies that make breast binders about marketing them to minors.
Most doctors' groups and the ACLU are against these changes.
The public has 60 days to share their thoughts on the proposals.
If the rules are put into effect, hospitals that don't follow them might have to close.
The Trump administration proposed pulling federal funding from hospitals providing gender-affirming care to minors and prohibiting Medicaid from paying for such treatments.
The FDA warned makers of breast binders about illegally marketing their products to minors with gender dysphoria.
Most major medical groups oppose the changes, stating they intrude on physician-patient relationships and jeopardize care for everyone.
The public has 60 days to comment on the proposals, which, if enacted, would effectively shut down non-compliant hospitals.
The ACLU vowed to challenge the rules in court.
- Who
- Trump administration, including Health Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz
- What
- Proposed actions to end gender-affirming care for Americans under 18, including pulling federal funding and prohibiting Medicaid payments
- When
- Proposals announced on a Thursday, with a 60-day public comment period
- Where
- United States
- Why
- To reflect President Donald Trump's focus on not recognizing transgender or nonbinary people and to flip the healthcare script to a unifying issue for Republicans
- Proposed Actions
- Pull federal funding from hospitals providing gender-affirming care to minors, prohibit Medicaid from paying for such treatments, warn makers of breast binders about illegal marketing to minors
- Key Figures
- Health Secretary Robert F. Kennedy Jr., Dr. Mehmet Oz (Head of CMS), President Donald Trump
- Public Comment Period
- 60 days
- Opposition
- Most major medical groups, ACLU
- Potential Impact
- Effectively shut down non-compliant hospitals
- FDA Action
- Warned makers of breast binders about illegal marketing to minors with gender dysphoria